Clinical Trials Directory

Trials / Conditions / Undifferentiated Fallopian Tube Carcinoma

Undifferentiated Fallopian Tube Carcinoma

6 registered clinical trials studyying Undifferentiated Fallopian Tube Carcinoma.

StatusTrialSponsorPhase
CompletedPembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube,
NCT02853318
Roswell Park Cancer InstitutePhase 2
CompletedVaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavi
NCT02111941
Mayo ClinicEARLY_Phase 1
UnknownDiet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previo
NCT00719303
Gynecologic Oncology GroupPhase 3
CompletedIntraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelia
NCT01074411
National Cancer Institute (NCI)Phase 1
TerminatedYKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal
NCT00899093
Gynecologic Oncology Group—
CompletedCarboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian
NCT00262847
National Cancer Institute (NCI)Phase 3